Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions

Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions Publisher Pubmed

Khoeeniha MK¹ ; Esfandyarimanesh M² ; Behrouz H¹ ; Amini M³ ; Varnamkhast BS² ; Atyabi F^{1, 2} ; Dinarvand R^{1, 2}

Show Affiliations

1. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, Iran
2. Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Current Drug Delivery Published:2017

Abstract

Background: Cabazitaxel (CBZ) is a new taxane approved by FDA for treatment of castration-resistant prostate cancer not responding to docetaxel. However, CBZ is not a suitable substrate for p-glycoprotein 60, an efflux pump which transports anticancer drugs out of malignant cells and is therefore a promising drug for treatment of multidrug resistant tumors. Similar to other taxanes, the presence of Tween 80 in the CBZ formulation shows that it is insoluble in water. Methods: In order to increase the solubility and circulation time of this drug, CBZ-human serum albumin (HSA) conjugate was synthesized. The designed linker was composed of methacrylic acid and N-acetyl cysteine to increase the solubility of CBZ and to increase the efficiency of conjugation. Targeting was performed by poly(ethylene glycol)-folic acid amide bound formation with carboxyl groups of HSA during in the step of nanoparticle formation. Cytotoxicity of nanoparticles was evaluated in vitro on HT-29, as a folate negative cell line, and MDA-MB-231, as a folate positive cell line. Results: H-NMR, Gel Permeation Chromatography, High Pressure Liquid Chromatography and UV spectrophotometry analysis confirmed the composition of conjugates. The resulting nanoparticles had a spherical shape, narrow size distribution and mean diameter of 138 nm. The efficiency of conjugation was 41.6 %. The IC50 of CBZ in targeted nanoparticles was 10.1 and 17.4% lower than that of the free CBZ for HT-29 and MDA-MB-231 cells, respectively. Conclusion: This designed drug delivery system was more water-soluble and had enhanced in vitro characteristics and higher cytotoxic activity on cancer cells. © 2017 Bentham Science Publishers.

Related Docs

View other Related Docs

1. Enhanced Cellular Cytotoxicity and Antibacterial Activity of 18-Β-Glycyrrhetinic Acid by Albumin-Conjugated Plga Nanoparticles, Drug Research (2015)

2. Biotin/Folate-Decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer, Chemical Biology and Drug Design (2016)

3. Optimization of Docetaxel Loading Conditions in Liposomes: Proposing Potential Products for Metastatic Breast Carcinoma Chemotherapy, Scientific Reports (2020)

4. Albumin Nanostructures As Advanced Drug Delivery Systems, Expert Opinion on Drug Delivery (2016)

5. Combination Therapy of Macromolecules and Small Molecules: Approaches, Advantages, and Limitations, Nanostructures for Cancer Therapy (2017)

6. Phbv/Plga Nanoparticles for Enhanced Delivery of 5-Fluorouracil As Promising Treatment of Colon Cancer, Pharmaceutical Development and Technology (2020)

7. Nanomil-100(Fe) Containing Docetaxel for Breast Cancer Therapy, Artificial Cells# Nanomedicine and Biotechnology (2018)

8. Cross-Linked Polysaccharides in Drug Delivery, Tailor-Made Polysaccharides in Drug Delivery (2022)

Experts (# of related papers)

View all Related Experts

Rassoul Dinarvand (5)

Mohsen Amini (3)

Style	Citing Format
MLA	Khoeeniha MK, et al.. "Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions." Current Drug Delivery, vol. 14, no. 8, 2017, pp. 1120-1129.
APA	Khoeeniha MK, Esfandyarimanesh M, Behrouz H, Amini M, Varnamkhast BS, Atyabi F, Dinarvand R (2017). Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions. Current Drug Delivery, 14(8), 1120-1129.
Chicago	Khoeeniha MK, Esfandyarimanesh M, Behrouz H, Amini M, Varnamkhast BS, Atyabi F, Dinarvand R. "Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions." Current Drug Delivery 14, no. 8 (2017): 1120-1129.
Harvard	Khoeeniha MK et al. (2017) 'Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions', Current Drug Delivery, 14(8), pp. 1120-1129.
Vancouver	Khoeeniha MK, Esfandyarimanesh M, Behrouz H, Amini M, Varnamkhast BS, Atyabi F, et al.. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions. Current Drug Delivery. 2017;14(8):1120-1129.
BibTex	@article{ author = {Khoeeniha MK and Esfandyarimanesh M and Behrouz H and Amini M and Varnamkhast BS and Atyabi F and Dinarvand R}, title = {Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions}, journal = {Current Drug Delivery}, volume = {14}, number = {8}, pages = {1120-1129}, year = {2017} }
RIS	TY - JOUR AU - Khoeeniha MK AU - Esfandyarimanesh M AU - Behrouz H AU - Amini M AU - Varnamkhast BS AU - Atyabi F AU - Dinarvand R TI - Targeted Delivery of Cabazitaxel by Conjugation to Albumin-Peg-Folate Nanoparticles Using a Cysteine-Acrylate Linker and Simple Synthesis Conditions JO - Current Drug Delivery VL - 14 IS - 8 SP - 1120 EP - 1129 PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract